Skip to main content
Clinical Trials/NCT01406964
NCT01406964CompletedNot Applicable

Chlamidia Antibodies Test for Tubal Factor Screening

Instituto Valenciano de Infertilidad, IVI VALENCIA2 sites in 1 country60 target enrollmentStarted: July 1, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
2
Primary Endpoint
Pregnancy outcome using the two different treatments.

Study Overview

Brief Summary

The aim of this study is to evaluate the usefulness of a Chlamydia Antibody Test for screening of tubal factor in patients who undergo artificial insemination.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 38 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age < 38 years
  • Treatment intrauterine insemination

Exclusion Criteria

  • Insulin dependent diabetes
  • Thyroid disease
  • Severe male factor
  • Policystic ovarian syndrome
  • Previous abdominal or uterine surgery
  • Prevous abdominal or genital infections
  • Uterine myomas
  • Hidrosalpinx
  • Uterine congenital abnormalities

Outcomes

Primary Outcomes

Pregnancy outcome using the two different treatments.

Time Frame: 6 months

Pregnancy rate, cumulative pregnancy rate and ectopic pregnancy rate in order to evaluate de usefulness of the CAT test as a predictor of tubal pathology.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials